Allarity Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$11,901,000 over the previous period. Total operating expenses were $17,892,000.
Profit Margin
| 2014 | 9.97K | -68.66K | -688.4% |
|---|---|---|---|
| 2015 | 362.28K | -1.14M | -316.59% |
| 2017 | 1.45M | -4.89M | -335.69% |
| 2019 | 120K | -14.4M | -12000% |
| 2020 | 0 | -5.07M | |
| 2021 | 0 | -26.64M | |
| 2022 | 0 | -16.05M | |
| 2023 | 0 | -11.90M |
ALLR Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Revenue | 0 | 0 | 0 | 0 | 120K | 1.45M | 362.28K | 9.97K |
Cost of revenue | 37K | 120K | 106K | 86K | 0 | 2.22M | 0 | 55.82K |
Gross profit | -37K | -120K | -106K | -86K | 120K | -761.49K | 362.28K | -45.85K |
Operating exp. | ||||||||
Research and development | 7.86M | 6.93M | 14.19M | 5.12M | 6.36M | 0 | 0 | 0 |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 17.89M | 16.89M | 26.55M | 9.22M | 10.23M | 3.08M | 1.75M | 22.80K |
Operating income | -17.92M | -34.46M | -26.55M | -9.22M | -17.61M | -3.84M | -1.39M | -68.66K |
Other income (expenses), net | 5.31M | 16.88M | 41K | 1.9M | -1.36M | -1.14M | -130.57K | 0 |
Income before tax | -12.61M | -17.57M | -26.51M | -7.23M | -18.97M | -4.99M | -1.52M | -68.66K |
Income tax expense | -717K | -1.52M | 133K | -2.16M | -4.57M | 95.08K | 380.15K | 0 |
Net income | -11.90M | -16.05M | -26.64M | -5.07M | -14.4M | -4.89M | -1.14M | -68.66K |
Earnings per share | ||||||||
Basic EPS | -0.01 | -47.19K | -117.33K | -1.69M | -127.05K | 0 | 0 | -0.05 |
Diluted EPS | -0.01 | -47.19K | -235.12K | -1.69M | -127.05K | 0 | 0 | -0.05 |
| Data source | Data source | Data source |